1
|
Pulakat L. A role for misaligned gene expression of fetal gene program in the loss of female-specific cardiovascular protection in young obese and diabetic females. Front Endocrinol (Lausanne) 2023; 14:1108449. [PMID: 36909327 PMCID: PMC9995961 DOI: 10.3389/fendo.2023.1108449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2022] [Accepted: 02/06/2023] [Indexed: 02/25/2023] Open
Abstract
Healthy, premenopausal women have the advantage of female-specific cardiovascular protection compared to age-matched healthy men. However, pathologies such as obesity and Type 2 diabetes mellitus (T2DM) cause losing of this female-specific cardiovascular protection in young, obese and diabetic females. Molecular mechanisms underlying this loss of female-specific cardiovascular protection in young, obese and diabetic females are not clearly elucidated. This review takes a close look at the latest advances in our understanding of sex differences in adult cardiac gene expression patterns in health and disease. Based on the emerging data, this review proposes that female biased gene expression patterns in healthy adult hearts of human and pre-clinical models support the existence of active fetal gene program in healthy, premenopausal female heart compared to age-matched healthy male heart. However, the misalignment of gene expression pattern in this female-specific active cardiac fetal gene program caused by pathologies such as obesity and T2DM may contribute to the loss of female-specific cardiovascular protection in young, obese and diabetic females.
Collapse
Affiliation(s)
- Lakshmi Pulakat
- Molecular Cardiology Research Institute, Tufts Medical Center, and Department of Medicine, Tufts University School of Medicine, Boston, MA, United States
| |
Collapse
|
2
|
Leo I, Nakou E, de Marvao A, Wong J, Bucciarelli-Ducci C. Imaging in Women with Heart Failure: Sex-specific Characteristics and Current Challenges. Card Fail Rev 2022; 8:e29. [PMID: 36303591 PMCID: PMC9585642 DOI: 10.15420/cfr.2022.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Accepted: 06/16/2022] [Indexed: 11/30/2022] Open
Abstract
Cardiovascular disease (CVD) represents a significant threat to women's health. Heart failure (HF) is one CVD that still has an increasing incidence and about half of all cases involve women. HF is characterised by strong sex-specific features in aetiology, clinical manifestation and outcomes. Women are more likely to have hypertensive heart disease and HF with preserved ejection fraction, they experience worse quality of life but have a better overall survival rate. Women's hearts also have unique morphological characteristics that should be considered during cardiovascular assessment. It is important to understand and highlight these sex-specific features to be able to provide a tailored diagnostic approach and therapeutic management. The aim of this article is to review these aspects together with the challenges and the unique characteristics of different imaging modalities used for the diagnosis and follow-up of women with HF.
Collapse
Affiliation(s)
- Isabella Leo
- Department of Cardiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London, UK.,Department of Medical and Surgical Sciences, Magna Graecia University Catanzaro, Italy
| | - Eleni Nakou
- Department of Cardiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London, UK
| | - Antonio de Marvao
- Medical Research Council, London Institute of Medical Sciences, Imperial College London London, UK
| | - Joyce Wong
- Department of Cardiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London, UK
| | - Chiara Bucciarelli-Ducci
- Department of Cardiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London, UK.,School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London London, UK
| |
Collapse
|
3
|
Armeni E, Delialis D, Georgiopoulos G, Augoulea A, Stergiotis S, Chatzivasileiou P, Rizos D, Kaparos G, Baka S, Paschou SA, Mavraganis G, Patras R, Panoulis K, Lambrinoudaki I, Stamatelopoulos K. Serum prolactin levels interact with menstrual fluctuations of arterial stiffness. Hellenic J Cardiol 2021; 63:89-91. [PMID: 34015467 DOI: 10.1016/j.hjc.2021.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 04/21/2021] [Accepted: 05/06/2021] [Indexed: 11/27/2022] Open
Affiliation(s)
- Eleni Armeni
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Dimitrios Delialis
- Laboratory of Vascular Pathophysiology, Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, 80 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Georgios Georgiopoulos
- Laboratory of Vascular Pathophysiology, Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, 80 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Areti Augoulea
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Stefanos Stergiotis
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Panagiota Chatzivasileiou
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Demetrios Rizos
- Hormonal Laboratory, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - George Kaparos
- Hormonal Laboratory, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Stavroula Baka
- Hormonal Laboratory, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Stavroula A Paschou
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Georgios Mavraganis
- Laboratory of Vascular Pathophysiology, Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, 80 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Raphael Patras
- Laboratory of Vascular Pathophysiology, Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, 80 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Konstantinos Panoulis
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Irene Lambrinoudaki
- Menopause Clinic, 2(nd) Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 76 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| | - Kimon Stamatelopoulos
- Laboratory of Vascular Pathophysiology, Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, 80 Vas. Sofias Street, PO Box 11528, Athens, Greece.
| |
Collapse
|
6
|
Sbarouni E, Georgiadou P, Manavi M, Analitis A, Beletsioti C, Niakas D, Iliodromitis E, Voudris V. Long-term outcomes and quality of life following acute type A aortic dissection. Hellenic J Cardiol 2021; 62:463-465. [PMID: 33524616 DOI: 10.1016/j.hjc.2021.01.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Revised: 01/13/2021] [Accepted: 01/25/2021] [Indexed: 11/29/2022] Open
Affiliation(s)
- Eftihia Sbarouni
- Interventional Cardiology, Onassis Cardiac Surgery Center, Athens, Greece
| | | | - Marina Manavi
- Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece
| | - Antonis Analitis
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Greece
| | | | - Dimitrios Niakas
- Μedical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Efstathios Iliodromitis
- Μedical School, National and Kapodistrian University of Athens, Athens, Greece; Attikon University Hospital, Department of Cardiology, Greece
| | - Vassilis Voudris
- Interventional Cardiology, Onassis Cardiac Surgery Center, Athens, Greece
| |
Collapse
|